Company Data
TScan Therapeutics Inc.
Ticker
TCRX
Current Price
$2.17 -0.91%
Market Cap
$115.8M
Price Target
Refer to Report
Volume
493.9K
52wk Range
$1.99 - $9.69
Overview
TScan Therapeutics Inc is a biopharmaceutical company focused on the development of T-cell receptor (TCR) engineered T cell therapies (TCR-T) for the treatment of patients with cancer. The company’s lead liquid tumor TCR-T therapy candidates, TSC-100 and TSC-101, are in development for the treatment of patients with hematologic malignancies to eliminate residual leukemia and prevent relapse after hematopoietic stem cell transplantation. It is also developing multiplexed TCR-T therapy candidates for the treatment of various solid tumors.